Resveratrol inhibits MRGPRX2-mediated mast cell activation via Nrf2 pathway

Copyright © 2021. Published by Elsevier B.V..

Mast cells (MCs) are crucial effectors in inflammation and allergic reactions. The Mas-related G-protein-coupled receptor X2 (MRGPRX2) was the MC-specific receptor and play a key role in IgE-independent allergic reactions. The activation of the Nuclear factor erythroid derived 2-related factor 2 (Nrf2) is involved in IgE-mediated MC degranulation. Resveratrol (Res) is a polyphenolic compound in red wine and has been reported to exert a variety of pharmacological effects. In the current study, we investigated the effect of Res in regulating MRGPRX2-mediated MC activation and its underlyingmechanism. We demonstrated that Res reduced compound 48/80 (C48/80)-induced calcium flux in MCs and inhibited MCs degranulation in vitro. Res also suppressed C48/80-induced hind paw extravasation, active systemic anaphylaxis, and MCs degranulation in mouse models of pseudo-allergy in vivo. Furthermore, PCR and immunohistochemistry assay suggest that Res up-regulates Nrf2 expression and Nrf2 inhibitor attenuates the protective effects of Res. In conclusion, Res exerts an inhibitory effect on MRGPRX2-mediated MCs activation by targeting Nrf2 pathway and may present a promising new therapeutic agent for the treatment of MRGPRX2-dependent anaphylactoid reactions.

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:93

Enthalten in:

International immunopharmacology - 93(2021) vom: 01. Apr., Seite 107426

Sprache:

Englisch

Beteiligte Personen:

Wang, Jue [VerfasserIn]
Zhang, Yongjing [VerfasserIn]
Hu, Shiling [VerfasserIn]
Ge, Shuai [VerfasserIn]
Jia, Min [VerfasserIn]
Wang, Nan [VerfasserIn]

Links:

Volltext

Themen:

Anti-Allergic Agents
Journal Article
MRGPRX2
Mast cell
Mrgprx2 protein, mouse
NF-E2-Related Factor 2
Nfe2l2 protein, mouse
Nrf2
Q369O8926L
Receptors, G-Protein-Coupled
Resveratrol

Anmerkungen:

Date Completed 28.05.2021

Date Revised 28.05.2021

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.intimp.2021.107426

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM321105648